fincash logo SOLUTIONS

Fincash » Search » Piramal Enterprises Ltd

Piramal Enterprises Ltd

Updated on July 10, 2019

Stock/Share Code - PEL

Piramal Enterprises Limited (PEL) (including its subsidiaries) is one of Indias large diversified companies, with a presence in Healthcare, Healthcare Insights & Analytics business and Financial Services. In Pharmaceuticals, through an end-to-end manufacturing capabilities across its manufacturing facilities and a large global distribution network, the Company sells a portfolio of niche differentiated pharma products and provides an entire pool of pharma services (including in the areas of injectable, HPAPI etc.). In Financial Services, PEL provides comprehensive financing solutions to real estate companies. Healthcare Insights & Analytics business, Decision Resources Group, is the premier provider of healthcare analytics, data & insight products and services to the worlds leading pharma, biotech and medical technology companies and enables them to take informed business decisions.

Below is the details of PEL Piramal Enterprises Ltd

Market Cap₹44,159 Cr.
Current Price ₹2,078 as on 15 Jul 19
52 Week High / Low Price₹3,307.95 / ₹1,794.9
Face Value₹2
Stock P/E112.60
Book Value₹982.89
Dividend Yield1.02 %
ROCE6.20 %
ROE3.31 %
Sales Growth (3yrs)11.05 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has been maintaining a healthy dividend payout of 54.63%
Cons: Company has low interest coverage ratio. Promoter's stake has decreased Company has a low return on equity of 5.41% for last 3 years.

Piramal Enterprises Ltd Price Chart

Piramal Enterprises Ltd Price Chart

Piramal Enterprises Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹148.55 26.06 ₹98,336.74 Cr. 0.49 ₹635.88 Cr. -52.63 2.68 7163.92 10.41
2. Cipla ₹550.55 29.66 ₹45,028.9 Cr. 0.54 ₹357.68 Cr. 57.90 19.09 4403.98 9.64
3. Dr Reddy's Labs ₹2,627.6 22.81 ₹44,478.27 Cr. 0.75 ₹455.4 Cr. 67.36 13.39 4029.60 7.75
4. Piramal Enterp. 112.60 ₹44,159.07 Cr. 1.02 -₹62.2 Cr. -125.38 0.96 1012.61 6.20
5. Piramal Enterp. 25.32 ₹44,159.07 Cr. 1.02 ₹456.86 Cr. -88.42 23.02 3679.67 8.85
6. Aurobindo Pharma ₹575.6 16.21 ₹39,396.97 Cr. 0.37 ₹585.38 Cr. 15.67 30.70 5292.20 22.85
7. Biocon ₹252.7 43.80 ₹32,514 Cr. 0.18 ₹213.7 Cr. 63.88 30.72 1528.80 8.41
8. Torrent Pharma. ₹18.9 36.27 ₹26,480.39 Cr. 0.89 -₹152 Cr. -37.72 8.67 1856.00 13.23

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Piramal Enterprises Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019
YOY Sales Growth %48.48%53.22%-31.56%-11.59%-40.65%-33.22%42.98%8.56%41.02%12.8%2.21%0.96%
Material Cost %20.48%17.49%32.79%34.28%27.37%28.25%22.57%29.39%23.33%19.74%20.23%31.02%
Employee Cost %8.62%7.9%15.11%10.21%17.04%12.92%12.38%12.64%12.2%11.56%12.37%8.43%
Operating Profit541722164201137314348416373516416373
OPM %52%60%27%22%22%39%40%41%43%57%47%37%
Other Income1282281595017317827262-1,101294-6430
Profit before tax30251877236522494371-1,057445-98-81
Tax %15%14%22%51%36%33%13%34%-3%19%31%23%
Net Profit25844860114215181245-1,091358-67-62

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales Growth %13.52%19.3%21.02%14.45%-69.28%41.63%21.49%42.05%20.64%40.93%11.28%-12.68%%
Material Cost %40.51%41%40.59%41.59%48.81%52.66%50.71%37.57%36.35%26.16%24.9%26.93%%
Manufacturing Cost %6.75%5.56%4.7%4.11%9.58%6.86%7.19%5.72%6.17%4.41%5.56%7.3%%
Employee Cost %11.33%11.86%10.36%10.98%17.79%13.16%11.72%10.73%11.54%10.67%9.84%13.46%%
Other Cost %24.75%20.97%26.74%21.48%47.11%39.2%39.51%33.25%141.51%20.19%10.96%15.3%%
Operating Profit267394408579-190-137-128254-2,2951,3051,8361,2171,678
OPM %17%21%18%22%-23%-12%-9%13%-96%39%49%37%46%
Other Income658117114716,8965343782653,337545357638-842
Profit before tax22233331447716,567121-248-370646984920753-792
Tax %15%9%12%7%22%-8%7%-0%42%-1%16%31%
Net Profit18830127544312,897131-232-370373996777518-862
EPS in Rs7.7313.5612.3920.19761.724.710.000.0017.4357.3744.7628.76
Dividend Payout %39%29%32%25%2%231%-130%-245%93%30%47%87%

Compounded Sales Growth

  • 10 Years:: 5.56%
  • 5 Years:: 18.60%
  • 3 Years:: 11.05%
  • TTM:: 11.64%

Compounded Profit Growth

  • 10 Years:: 5.66%
  • 3 Years:: 36.99%
  • TTM:: -266.25%

Return on Equity

  • 10 Years:: 3.19%
  • 5 Years:: 3.44%
  • 3 Years:: 5.41%
  • Last Year:: 3.31%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital80424242343535353535353637
Preference Capital38.3700000000000
Equity Capital41.841.841.841.833.5834.5134.5134.5134.5134.5134.5136.0536.89
Other Liabilities4025035626461,1891,3001,2882,0791,2569049715,3867,244
Trade Payables202.83246.83257.46281.83276.13312.61328.64248.14277.1497.92575.59547.41564.8
Total Liabilities1,8142,0242,7282,80713,17413,76816,49017,09916,56527,26525,64936,96638,006
Fixed Assets8708081,0191,0746667607737807569541,0751,8071,876
Gross Block1152.561137.231427.811570.25976.871197.491287.591365.581461.471032.061246.362086.58
Accumulated Depreciation282.41329409.09496.36310.58437.07514.29585.32705.3877.62171.56279.39
Other Assets7711,0391,5331,49010,8955,7305,9284,5705,5248,1536,69811,31613,065
Trade receivables229.88302.14361.88273.07209.09242.48243.03256.27327.59404.58491.43492.96619.06
Cash Equivalents22.0534.0717.4715.641754.0313.2424.2431.8540.3939.48124.07554.8265.08
Loans n Advances292.62450.59865.93915.932855.94965.282792.783150.513610.232360.111791.781143.8810630.39
Total Assets1,8142,0242,7282,80713,17413,76816,49017,09916,56527,26525,64936,96638,006

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity170133-92564-4,705-755-1,752-1,749-3,369-7,131-6,348-4,910
Profit from operations313.09430.69438.07602.39-96.62-177.18-186.84179.86271.09993.05863.88712.22
Working Capital Changes-97.96-263.11-455.5352.59-397.31-515.31-1493.84-1881.56-3300.1-7799.39-7022.94-5446.85
Taxes paid-44.8-34.4-74.52-90.54-3413.76-62.15-71.56-65.02-297.55-324.59-188.62-175.84
Cash from Investing Activity-161-114-70-309,388-1,312-7911,6686,771-1,440-2,424-4,403
Fixed Assets Purchased-272.71-101.78-280.47-168.77-89.79-80.83-78.35-99.41-135.67-340.4-680.59-391.17
Fixed Assets Sold1.160.1727.931.8210245.763802.29973.992850.99791.4711.8570.351.19
Capital WIP129.48-19.091.49-4.2313.98-17.31000000
Investments purchased-47.56-5-1.750-24077.72-13309.51-7641.49-5982.96-17660.99-10483.9900
Investments sold02.770.03022972.5414301.047494.456682.0526461.410582.9600
Cash from Financing Activity1-8145-536-3,0324132,55287-3,3988,5568,8879,690
Proceeds from Shares04.010000000001781.57
Proceeds from Borrowings7133.8514190.4815426.2815287.214135.526491.1525948.8433572.7818709.9830375.8639188.7442419.83
Repayment of Borrowings-6927.24-14100.44-15003.27-15565.6-14505.86-5602.98-22637.8-32322.09-20739.33-20741.91-30053.8-38694.92
Interest Paid-38.37-72.41-174.82-154.48-83.08-199.8-407.86-812.08-313.55-305.63-244.22-324.91
Dividends Paid-130.53-11.94-87.79-87.79-112.86-200.65-301.99-300.48-901.26-640.71-3.52-359.95
Net Cash Flow1112-17-21,650-1,654964-15115376

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %20%27%26%29%6%2%1%3%4%8%8%6%
Debtor Days525857389477634750444855
Inventory Turnover7.337.998.579.253.164.645.307.087.739.7210.499.06

Announcements & News

Recent Announcements

Credit Ratings

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Piramal Enterprises Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.